Supplying Medicines and Supplements to Côte d'Ivoire
A practical guide for Ivorian importers, wholesalers and hospital buyers who source from abroad, and for manufacturers and exporters worldwide selling into Côte d'Ivoire.
Côte d'Ivoire imports over 90% of its medicines, in a market worth around €537 million. Its regulator, AIRP, set up in 2017, is preparing for WHO benchmarking at maturity level 3 and has issued a string of new decisions since 2024, including formal reliance rules.
Registration follows the rules of the West African Economic and Monetary Union (UEMOA), which its French-speaking neighbours share.
Côte d'Ivoire at a glance
| Regulator | Autorité Ivoirienne de Régulation Pharmaceutique (AIRP), created in 2017 |
|---|---|
| Registration | A CTD dossier under UEMOA Regulation 04/2020, with full, abridged and priority routes. Module 1 must be in French |
| Reliance | A priority route for WHO-prequalified and stringent-authority-approved products, formal reliance decisions in 2024 and 2025, and the ECOWAS joint assessment |
| Public buyer | Nouvelle Pharmacie de la Santé Publique (NPSP), which supplies public health facilities |
| Pricing | Prices approved by AIRP, with set multipliers on the wholesale price for imported and local products |
How to supply medicines to Côte d'Ivoire
- Decide who applies. The manufacturer or licence holder applies, or a local representative with a power of attorney. Most products reach the market through local representation agencies.
- Prepare the dossier. A CTD dossier, with Module 1 in French, a CoPP and the plant's GMP evidence.
- Choose the route. Full, abridged or priority review, or the ECOWAS joint assessment if you also want other West African markets.
- Supply. Only AIRP-licensed establishments can import, and every import needs AIRP's authorisation. Private supply runs through a few wholesalers to about 2,000 pharmacies; public supply goes through NPSP.
A special import authorisation (ASI) covers unregistered products, and a March 2026 AIRP decision set emergency rules for unapproved products. See named-patient and special import and government tender supply.
Supplements
Food supplements fall under AIRP, which ran a declaration campaign for health products in 2024 and 2025. Health claims in advertising need AIRP's prior approval. We help brands get supplements made under their own label by GMP-certified contract manufacturers: see nutraceutical private label.
What people in Côte d'Ivoire search for
Semrush does not track Google searches in Côte d'Ivoire, so we cannot show local search data. The market itself is import-led, with over 90% of medicines imported.
Supplements we can help you make
Medicines widely bought in Côte d'Ivoire include antimalarials, antibiotics and treatments for chronic diseases. Some examples we list:
Documents to ask your supplier for
- A Certificate of a Pharmaceutical Product (CoPP) in WHO format.
- The plant's GMP evidence, such as a WHO-GMP, EU-GMP or PIC/S certificate, plus any inspection by your regulator.
- The registration dossier (CTD or ACTD), with bioequivalence data for generics where required.
- Stability data for hot climates.
- A Certificate of Analysis for every batch.
Not sure a supplier is genuine? Read how to verify a pharmaceutical supplier. For the neighbouring markets, see our Sub-Saharan Africa import guide.
Sourcing for Côte d'Ivoire?
Send the product, strength, quantity and the documents your regulator needs. We will match you with GMP-certified manufacturers and suppliers who can serve your market, wherever they are based.
Send your requirement Talk to our team